{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T09:10:23Z","timestamp":1742893823045,"version":"3.40.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,25]]},"DOI":"10.7759\/cureus.81132","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T08:47:08Z","timestamp":1742892428000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation and Treatment Adherence of a Child With Atopic Dermatitis Complicated by Parental Steroid Phobia: A Case Report"],"prefix":"10.7759","author":[{"given":"Ryosuke","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemi","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan SM","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020, 396:345-60. 10.1016\/S0140-6736(20)31286-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler CF 4th","year":"2023","unstructured":"Schuler CF 4th, Billi AC, Maverakis E, Tsoi LC, Gudjonsson JE. Novel insights into atopic dermatitis. J Allergy Clin Immunol. 2023, 151:1145-54. 10.1016\/j.jaci.2022.10.023","journal-title":"J Allergy Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2015.27.5.499","article-title":"Topical corticosteroid phobia among parents of children with atopic eczema in Korea","volume":"27","author":"Lee JY","year":"2015","unstructured":"Lee JY, Her Y, Kim CW, Kim SS. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol. 2015, 27:499-506. 10.5021\/ad.2015.27.5.499","journal-title":"Ann Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S426199","article-title":"Topical corticosteroid phobia among parents of children with atopic dermatitis (eczema) - a cross-sectional study","volume":"17","author":"Albogami M","year":"2023","unstructured":"Albogami M, AlJomaie M, Almarri S, et al.. Topical corticosteroid phobia among parents of children with atopic dermatitis (eczema) - a cross-sectional study. Patient Prefer Adherence. 2023, 17:2761-72. 10.2147\/PPA.S426199","journal-title":"Patient Prefer Adherence"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13452","article-title":"Steroid phobia in children with atopic dermatitis and their caregivers in Singapore","volume":"33","author":"Salas-Walinsundin WM","year":"2020","unstructured":"Salas-Walinsundin WM, Wong V, Chong JH, Koh MJ. Steroid phobia in children with atopic dermatitis and their caregivers in Singapore. Dermatol Ther. 2020, 33:e13452. 10.1111\/dth.13452","journal-title":"Dermatol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12331","article-title":"Factors contributing to poor treatment outcomes in childhood atopic dermatitis","volume":"56","author":"Sokolova A","year":"2015","unstructured":"Sokolova A, Smith SD. Factors contributing to poor treatment outcomes in childhood atopic dermatitis. Australas J Dermatol. 2015, 56:252-7. 10.1111\/ajd.12331","journal-title":"Australas J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076493","article-title":"TOPICOP\u00a9: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents","volume":"8","author":"Moret L","year":"2013","unstructured":"Moret L, Anthoine E, Aubert-Wastiaux H, et al.. TOPICOP\u00a9: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One. 2013, 8:e76493. 10.1371\/journal.pone.0076493","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17544","article-title":"English version of clinical practice guidelines for the management of atopic dermatitis 2024","volume":"52","author":"Saeki H","year":"2025","unstructured":"Saeki H, Ohya Y, Arakawa H, et al.. English version of clinical practice guidelines for the management of atopic dermatitis 2024. J Dermatol. 2025, 52:e70-e142. 10.1111\/1346-8138.17544","journal-title":"J Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1186\/s13223-023-00844-w","article-title":"Patient education in atopic dermatitis: a scoping review","volume":"19","author":"Wilken B","year":"2023","unstructured":"Wilken B, Zaman M, Asai Y. Patient education in atopic dermatitis: a scoping review. Allergy Asthma Clin Immunol. 2023, 19:89.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13784","article-title":"Topical corticosteroid phobia among caretakers of children with atopic dermatitis: a cross-sectional study using TOPICOP in Japan","volume":"36","author":"Saito-Abe M","year":"2019","unstructured":"Saito-Abe M, Futamura M, Yamamoto-Hanada K, Yang L, Suzuki K, Ohya Y. Topical corticosteroid phobia among caretakers of children with atopic dermatitis: a cross-sectional study using TOPICOP in Japan. Pediatr Dermatol. 2019, 36:311-6. 10.1111\/pde.13784","journal-title":"Pediatr Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15798","article-title":"Post-hoc safety\/efficacy analyses from pediatric delgocitinib atopic dermatitis trials","volume":"66","author":"Fukuie T","year":"2024","unstructured":"Fukuie T, Toyama H, Tanaka M, Ohashi-Doi K, Kabashima K. Post-hoc safety\/efficacy analyses from pediatric delgocitinib atopic dermatitis trials. Pediatr Int. 2024, 66:e15798. 10.1111\/ped.15798","journal-title":"Pediatr Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.08.004","article-title":"Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis","volume":"144","author":"Nakagawa H","year":"2019","unstructured":"Nakagawa H, Nemoto O, Igarashi A, Saeki H, Oda M, Kabashima K, Nagata T. Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis. J Allergy Clin Immunol. 2019, 144:1575-83. 10.1016\/j.jaci.2019.08.004","journal-title":"J Allergy Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346273-evaluation-and-treatment-adherence-of-a-child-with-atopic-dermatitis-complicated-by-parental-steroid-phobia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T08:47:11Z","timestamp":1742892431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346273-evaluation-and-treatment-adherence-of-a-child-with-atopic-dermatitis-complicated-by-parental-steroid-phobia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.81132","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}